A Study of ALX148 With Azacitidine for Higher Risk Myelodysplastic Syndrome

Condition:   Higher Risk Myelodysplastic Syndromes Interventions:   Drug: ALX148;   Drug: Azacitidine Sponsor:   ALX Oncology Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials